Dental materials science: HZB is part of a research project funded by DFG

Artificial and natural interzones on a tooth restored with non-degradable biomaterials are exposed to mechanical (left: stresses acting in compression, tension and shear) and biological challenges (right: bacterial attachment, penetration, and other interactions with biological media).

Artificial and natural interzones on a tooth restored with non-degradable biomaterials are exposed to mechanical (left: stresses acting in compression, tension and shear) and biological challenges (right: bacterial attachment, penetration, and other interactions with biological media). © P. Zaslansky/Charité.

How can dental restorations – such as fillings and crowns – be made to last longer? A new research group centered at Charité – Universitätsmedizin Berlin and Technische Universität (TU) Berlin plans to address this topic by utilizing approaches from both materials science and dentistry. The interdisciplinary ‘InterDent’ research group is funded by the German Research Foundation (DFG). It will receive an initial funding of €2.1 million Euro over three years. Partners also include the Helmholtz-Zentrum Berlin (HZB) and the Max Planck Institute of Colloids and Interfaces (MPI-KG).

The goal of the team is to create better dental materials by shedding light on the ways in which different materials interact with the surrounding tissues. One of the sub-projects aims at predicting the way in which dentine (the hard bony tissue that makes up the tooth´s core) changes over time, depending on the material used for the filling to which it is attached. Employing non-destructive, highly sensitive, high-resolution technology, the researchers will study the microstructure and chemical characteristics of dentine, tracking progressive changes over time as part of an  aging process known as ‘sclerosis’. “We want to use this approach in order to develop a model of sclerotic dentine which will enable us to gain a better understanding of changes in its structure and composition,” says Dr. Ioanna Mantouvalou of the HZB, who leads the sub-project together with Dr. Paul Zaslansky, the research group’s spokesperson, who is project leader at Charité’s Institute of Dental, Oral and Maxillary Medicine.


Charité /red.

  • Copy link

You might also be interested in

  • Protein crystallography at BESSY II: faster, better and more and more automatic
    Interview
    04.03.2026
    Protein crystallography at BESSY II: faster, better and more and more automatic
    Many diseases are linked to malfunctions of proteins in the organism. The three-dimensional architecture of these molecules is often highly complex, but it can provide valuable insights into biological processes and the development of drugs. X-ray diffraction at the MX beamlines of BESSY II can be used to decipher the 3D structure of proteins. To date, more than 5000 structures have been solved at the three MX beamlines. Here, we present a review and an outlook with  Manfred Weiss, head of the research group for macromolecular crystallography. 
  • Humboldt-Fellow at HZB-Institute for Solar Fuels: Alexander R. Uhl
    News
    02.03.2026
    Humboldt-Fellow at HZB-Institute for Solar Fuels: Alexander R. Uhl
    Alexander R. Uhl, UBC Okanagan School of Engineering in Kelowna, Canada, aims to develop with Roel van de Krol from the HZB Institute for Solar Fuels an efficient and inexpensive photoelectrolyser for producing hydrogen using sunlight. His stay is being funded by the Alexander von Humboldt Foundation.
  • 5000th protein structure at BESSY II: Starting point for a COVID drug
    Science Highlight
    26.02.2026
    5000th protein structure at BESSY II: Starting point for a COVID drug
    Many proteins have a complex architecture that enables biological functions. Molecules can bind to specific sites on a protein and alter its function. A team at HZB has now investigated the Nsp1 protein, which plays a role in infection with the SARS-CoV-2 virus. They analysed protein crystals, previously mixed with molecules from a fragment library, and discovered a total of 21 candidates as starting points for drug development. At the same time, they also decoded the 5000th structure at BESSY II.